Hologic earnings were $557.1M for the trailing 12 months ending Jun 28, 2025, with -17.6% growth year over year. The latest HOLX earnings report on Jun 28, 2025 announced Q2 2025 earnings of $194.9M, down 1,220.1% from last quarter. For the last reported fiscal year 2024 ending Sep 28, 2024, HOLX reported annual earnings of $789.5M, with 73.1% growth.
HOLX past earnings growth
How has HOLX's earnings growth performed historically?
On HOLX's earnings call on Invalid Date, Hologic (NASDAQ: HOLX) reported Q2 2025 earnings per share (EPS) of $0.87, up 4.82% year over year. Total HOLX earnings for the quarter were $194.90 million. In the same quarter last year, Hologic's earnings per share (EPS) was $0.83.
As of the last Hologic earnings report, Hologic is currently profitable. Hologic's net profit (also called net income) for the twelve months ending Jun 28, 2025 was $557.10 million, a 20.58% decrease year over year.
What was HOLX's earnings growth in the past year?
As of Hologic's earnings date in Invalid Date, Hologic's earnings has grown -17.63% year over year. This is 33.34 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 15.71%. HOLX earnings in the past year totalled $557.10 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.